Actelion

VENTAVIS

Manufacturer:

Actelion

Ventavis HCPCS:

Q4074

HCPCS Code Descriptor:

Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms

Category:

Q Code

Ventavis NDCs:

66215-0303-30, 66215-0302-30, 66215-0303-00, 66215-0302-00

Primary Type:

Cardiology

Generic/Specialty Status:

Single-Source

Route of Administration:

Inhalation

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Ventavis:

VENTAVIS is a Cardiology drug manufactured by Actelion and administered via the Inhalation route of administration. The Q Code: Q4074 is aligned to the drug VENTAVIS.

ACCESS PRICING AND MORE BY REGISTERING

Q4074 Added Date:

January 1, 2010

Q4074 Effective Date:

January 1, 2010

Q4074 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Ventavis billing and coding information.
Ventavis patient assistance information can be found through The Johnson and Johnson Patient Assistance Foundation at the URL: https://www.jjpaf.org/
VENTAVIS prescribing information can be found at the link below:
Information regarding VENTAVIS’s side effects can be found at MedlinePlus